Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Lamisil at Cream

Last content change checked dailysee data sync status

Active ingredient
Terbinafine Hydrochloride 1 g/100 g
Other brand names
Drug class
Allylamine Antifungal
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2025
Label revision date
January 9, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Terbinafine Hydrochloride 1 g/100 g
Other brand names
Drug class
Allylamine Antifungal
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2025
Label revision date
January 9, 2025
Manufacturer
Karo Healthcare Inc.
Registration number
NDA020980
NDC root
84485-3607
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

LAMISIL AT is a 1% antifungal cream designed to treat skin conditions caused by fungi, specifically jock itch (tinea cruris). It works by curing the infection and providing relief from uncomfortable symptoms such as itching, burning, cracking, and scaling associated with these conditions.

This cream is intended for effective relief, helping you feel more comfortable and free from the irritation caused by fungal infections.

Uses

If you're dealing with jock itch (a fungal infection also known as tinea cruris), this medication can help cure the condition effectively. It works by targeting the underlying cause of the infection, allowing you to get back to your normal activities without discomfort.

In addition to treating the infection, this medication also provides relief from the uncomfortable symptoms that often accompany jock itch, such as itching, burning, cracking, and scaling of the skin. You can expect to feel more comfortable and at ease as the treatment takes effect.

Dosage and Administration

To use this medication, start by breaking the seal on the tube using the tip of the cap. Before applying the medication, wash the affected area of your skin with soap and water, then dry it completely. You should apply the medication once a day, either in the morning or at night, for one week, unless your doctor advises otherwise. After each application, make sure to wash your hands to keep them clean.

If you are considering this medication for a child under 12 years old, it’s important to consult a doctor first to ensure it’s safe and appropriate for them.

What to Avoid

It's important to use this product safely and effectively. You should avoid applying it to your nails or scalp, and it should not be used in or near your mouth or eyes. Additionally, do not use this product for treating vaginal yeast infections. Following these guidelines will help ensure your safety and the best possible results.

Side Effects

When using this product, it's important to apply it only to the skin and avoid areas such as the nails, scalp, mouth, eyes, and vaginal area. If the product accidentally gets into your eyes, rinse them thoroughly with water. You should stop using the product and consult a doctor if you experience excessive irritation or if the irritation worsens.

Keep this product out of reach of children. If swallowed, seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for external use only, so please avoid applying it to your nails or scalp, and do not use it in or near your mouth or eyes. It is also not suitable for treating vaginal yeast infections. If the product accidentally gets into your eyes, rinse them thoroughly with water.

While using this product, if you experience excessive irritation or if the irritation worsens, stop using it and consult your doctor. Keep this product out of reach of children, and if it is swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed too much of this medication, it’s important to seek medical help immediately. You can do this by contacting a Poison Control Center or going to the nearest emergency room.

Signs of an overdose can vary, but they may include unusual symptoms that are not typical for you. If you notice anything concerning, don’t hesitate to reach out for help. Remember, acting quickly can make a significant difference in ensuring safety and health.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is currently no information available about the safety or use of Lamisil AT Cream (terbinafine hydrochloride cream) during pregnancy. This means that there are no specific guidelines, dosage adjustments, or precautions outlined for pregnant individuals.

Given this lack of information, it is advisable to consult with your healthcare provider before using this cream. They can help you weigh the potential risks and benefits based on your individual situation. Always prioritize your health and the health of your baby when considering any medication during pregnancy.

Lactation Use

If you are breastfeeding, you can use Lamisil AT Cream without specific warnings or recommendations against it. Currently, there is no information available about whether this cream passes into breast milk or if it poses any risk to your nursing infant.

As always, it's a good idea to consult with your healthcare provider if you have any concerns about using medications while breastfeeding. They can provide personalized advice based on your situation.

Pediatric Use

If you have a child under 12 years old, it's important to consult with a doctor before using this medication. For those aged 12 and older, you can use the product by breaking the seal with the tip of the cap and applying it once a day, either in the morning or at night, for one week or as directed by your doctor.

Always keep this medication out of reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center immediately.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver problems).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that you receive the safest and most effective treatment based on your individual needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that, based on the available information, this medication does not have known conflicts with other drugs or tests. However, every individual is different, and your healthcare provider can help ensure that your treatment plan is safe and effective for you. Always discuss any concerns or questions you may have regarding your medications or tests with them.

Storage and Handling

To ensure the safety and effectiveness of your product, always check that the seal on the tube is intact and visible before use. If the seal is broken, do not use the product.

For proper storage, keep the product at a controlled room temperature between 20-25°C (68-77°F). This helps maintain its quality and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is LAMISIL AT?

LAMISIL AT is a 1% antifungal cream used to cure most jock itch (tinea cruris) and relieve associated symptoms like itching, burning, cracking, and scaling.

How should I use LAMISIL AT?

For adults and children 12 years and over, apply LAMISIL AT once a day for 1 week after washing and drying the affected area. Always wash your hands after use.

What should I do if I experience irritation while using LAMISIL AT?

If you experience too much irritation or if it gets worse, stop using the product and consult a doctor.

Are there any precautions I should take when using LAMISIL AT?

Yes, do not use LAMISIL AT on nails or scalp, in or near the mouth or eyes, or for vaginal yeast infections. It is for external use only.

What should I do if LAMISIL AT gets into my eyes?

If LAMISIL AT comes into contact with your eyes, rinse thoroughly with water.

Is LAMISIL AT safe for children?

Children under 12 years should consult a doctor before using LAMISIL AT.

What should I do if I swallow LAMISIL AT?

If swallowed, seek medical help or contact a Poison Control Center immediately.

How should I store LAMISIL AT?

Store LAMISIL AT at a controlled room temperature of 20-25°C (68-77°F) and do not use it if the seal on the tube is broken.

Packaging Info

Below are the non-prescription pack sizes of Lamisil at Cream (terbinafine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Lamisil at Cream.
Details

Drug Information (PDF)

This file contains official product information for Lamisil at Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

LAMISIL AT is a topical cream formulation containing 1% terbinafine hydrochloride, indicated for the treatment of jock itch. The product is presented in a net weight of 12 grams (0.42 ounces) and is packaged in a recyclable carton. LAMISIL AT is distributed by Karo Healthcare Inc., located in Morristown, NJ, USA, and is manufactured in Canada. The trademarks associated with this product are owned or licensed by Karo Healthcare. ©2024 Karo Healthcare or its licensor.

Uses and Indications

This drug is indicated for the treatment of most cases of jock itch (tinea cruris). It effectively relieves associated symptoms, including itching, burning, cracking, and scaling.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

For adults and children aged 12 years and over, the following dosage and administration guidelines should be adhered to:

The seal of the tube should be broken using the tip of the cap to open it. Prior to application, the affected skin must be washed thoroughly with soap and water, followed by complete drying. The product should then be applied once daily, either in the morning or at night, for a duration of 1 week, or as directed by a healthcare professional. It is essential to wash hands thoroughly after each use to prevent unintentional transfer of the product.

For children under 12 years of age, it is recommended to consult a healthcare professional for appropriate guidance.

Contraindications

The product is contraindicated for use in the following situations:

  • Application on nails or scalp is not recommended.

  • Use in or near the mouth or eyes is contraindicated due to potential irritation or adverse effects.

  • The product should not be used for the treatment of vaginal yeast infections, as it is not indicated for this condition.

Warnings and Precautions

For external use only. This product is contraindicated for application on nails or the scalp, and it should not be used in or near the mouth or eyes. Additionally, it is not intended for the treatment of vaginal yeast infections.

When using this product, care must be taken to avoid contact with the eyes. In the event of eye contact, it is imperative to rinse thoroughly with water to mitigate potential irritation.

Users should discontinue use and consult a healthcare professional if excessive irritation occurs or if the condition worsens.

This product must be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for application on nails or the scalp, and it should not be used in or near the mouth or eyes, nor for the treatment of vaginal yeast infections.

During use, patients must take care to avoid contact with the eyes. In the event of eye contact, it is advised to rinse thoroughly with water. If excessive irritation occurs or worsens, patients are instructed to discontinue use and consult a healthcare professional.

Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are no specific drug interactions identified in the available data. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Lamisil at Cream (terbinafine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Lamisil at Cream.
Details

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended application involves using the tip of the cap to break the seal and opening the tube, with a dosage of once daily (either morning or night) for a duration of 1 week or as directed by a physician.

It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of Lamisil AT Cream (terbinafine hydrochloride cream) during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering the use of this medication in pregnant patients. Healthcare professionals should weigh the potential benefits against any unknown risks when prescribing this medication to women of childbearing potential. It is advisable to exercise caution and consider alternative treatments when necessary.

Lactation

There are no specific warnings or recommendations regarding the use of Lamisil AT Cream in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants from the use of Lamisil AT Cream during lactation.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that this product is not intended for use on nails or the scalp, and it should not be applied in or near the mouth or eyes. Additionally, it is important to clarify that this product is not indicated for the treatment of vaginal yeast infections.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience excessive irritation or if the irritation worsens. Furthermore, patients should be cautioned to avoid contact with the eyes while using this product. In case of eye contact, they should rinse thoroughly with water.

Storage and Handling

The product is supplied in a tube format. It is essential to ensure that the seal on the tube is intact and visible before use; the product should not be utilized if the seal is broken or not visible.

For optimal storage, the product should be maintained at a controlled room temperature ranging from 20 to 25°C (68 to 77°F). Proper handling and storage conditions are crucial to preserve the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Lamisil at Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Lamisil at Cream, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.